In addition to reduced brain size, NDD, and CHD, patients with variants in SLF2 or SMC5 were found to have ocular abnormalities, growth restriction, anemia, and skin hyperpigmentation, a condition recently named Atelis syndrome [22]. This evidence concerns the gene SMC5 and coronary artery disorder.